The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...
Morning Overview on MSN
Crispr reveals a new way to defeat resistant lung cancer
Drug resistance has long turned some of the most advanced lung cancer therapies into temporary victories, with tumors ...
Jefferies London Healthcare Conference 2025 November 20, 2025 9:30 AM ESTCompany ParticipantsPeter Dannenbaum - Vice ...
Researchers at Northwestern Medicine found that 65% of their lung cancer patients weren't eligible for screening. They were ...
FDA grants accelerated approval to Bayer's Hyrnuo and full approval to Amgen's Imdelltra, expanding treatment options for ...
The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...
Researchers uncovered a powerful weakness in lung cancer by shutting down a protein that helps tumors survive stress. When this protein, FSP1, was blocked, lung tumors in mice shrank dramatically, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback